Carlsmed targets $70M-$75M 2026 revenue with cervical and bilateral product launches amid 44% growth outlook
Source: SeekingAlpha
2026-02-25 19:48:21 ET
More on Carlsmed, Inc.
- Carlsmed, Inc. (CARL) Q4 2025 Earnings Call Transcript
- Carlsmed: Back To Where We Started
- Seeking Alpha’s Quant Rating on Carlsmed, Inc.
- Historical earnings data for Carlsmed, Inc.
- Financial information for Carlsmed, Inc.
Read the full article on Seeking Alpha
For further details see:
Carlsmed targets $70M–$75M 2026 revenue with cervical and bilateral product launches amid 44% growth outlook
Carlsmed Inc.
NASDAQ: CARL
CARL Trading
0.42% G/L:
$11.97 Last:
32,769 Volume:
$11.80 Open:
CARL Latest News
February 23, 2026 04:01:00 pm
Carlsmed, Inc. To Participate in the 2026 Canaccord Genuity Musculoskeletal Conference
February 18, 2026 04:05:00 pm
Carlsmed Announces first corra(TM) personalized Cervical Plating Procedure
